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Background: Riboflavin (RF) or vitamin B2 is known to have neuroprotective effects. In the present study, we report
the attenuation of the neuroprotective effects of RF under UV-B irradiation. Preconditioning of UV-B irradiated
riboflavin (UV-B-RF) showed attenuated neuroprotective effects compared to that of RF in SH-SY5Y neuroblostoma
cell line and primary cortical neurons in vitro and a rat model of cerebral ischemia in vivo.
Results: Results indicated that RF pretreatment significantly inhibited cell death and reduced LDH secretion compared
to that of the UV-B-RF pretreatment in primary cortical neuron cultures subjected to oxygen glucose deprivation
in vitro and cortical brain tissue subjected to ischemic injury in vivo. Further mechanistic studies using cortical neuron
cultures revealed that RF treatment induced increased miR-203 expression which in turn inhibited c-Jun expression
and increased neuronal cell survival. Functional assays clearly demonstrated that the UV-B-RF preconditioning failed to
sustain the increased expression of miR-203 and the decreased levels of c-Jun, mediating the neuroprotective effects of
RF. UV-B irradiation attenuated the neuroprotective effects of RF through modulation of the miR-203/c-Jun signaling
pathway.
Conclusion: Thus, the ability of UV-B to serve as a modulator of this neuroprotective signaling pathway warrants
further studies into its role as a regulator of other cytoprotective/neuroprotective signaling pathways.
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Cerebral stroke, a leading cause of death and disability
worldwide involves cerebral ischemia-reperfusion injury
and impaired blood flow resulting in neuronal cell death
[1,2]. Despite the recent efforts for improvement of treat-
ment strategies for cerebral stroke, prognosis of cerebral is-
chemia patients has remained largely unsatisfactory. This is
attributed to the lack of effective neuroprotective agents
for salvaging neuronal cell death as in most cases only the
recombinant tissue plasminogen activator (rtPA) is rou-
tinely used for treatment [2]. Therefore, the need for* Correspondence: dpm@cdri.res.in
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for cerebral stroke is critical.
Understanding of the complex pathophysiology of is-
chemic stroke is imperative for identifying promising
neuroprotective agents and therapeutic strategies [2].
Recent studies have established microRNAs (miRs) as
novel regulators of brain function with roles in cerebral
ischemia and injury, neuroprotection, and neurodegener-
ation [3-7].
At current rates, it takes a reasonably long period of
time for a lead compound to be developed into a clinic-
ally approved drug for cerebral ischemia [2,3]. An argu-
ably faster path to development is to repository dietary
agents or neutraceuticals as neuroprotective agents for
improvement of cerebral stroke outcome [8]. The insuf-
ficiency of vitamins and antioxidants leads to increasedl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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riboflavin (vitamin B2) is known to have promising neu-
roprotective effects [9-12]. However, RF contains a photo-
sensitive isoalloxazine ring making it vulnerable to the
atmospherically predominant UV-B radiation (280-315 nm)
induced photodegradation, which might compromise its
neuroprotective effects [13-15]. In the present study, we ex-
amined the neuroprotective effects of RF and UV-B-RF in a
rat model of cerebral ischemia and cortical neurons and
investigated the molecular mechanisms involved in this
process.
Methods
The human neuroblastoma SH-SY5Y was obtained from
American Type Culture Collection (ATCC, Rockville, MD).
Riboflavin, para-formaldehyde, sucrose, poly-l-lysine, 2,
3, 5-triphenyl tetrazolium chloride (TTC), Nembutal,
4′, 6-diamidino-2-phenylindole (DAPI) all are procured
from Sigma (St. Louis, MO, USA). The firefly luciferase
reporter plasmid (Genecopeia Inc., Rockville, MD, USA)
and the miRNA mimic was procured from Ambion
(Ambion, Austin, TX, USA). The Lipofectamine 2000
and RNAiMax were from Invitrogen (Invitrogen, Carlsbad,
CA,USA). The dual luciferase assay kit was purchased
from Promega (Promega, Madison, WI, USA). A 3–0
rounded-tip nylon monofilament suture was procured
from Ethicon. The cell counting kit-8 (CCK-8) was from
Dojinando Laboratory (Dojindo Molecular Technologies,
Inc. Rockville, MD,USA). The RT2miRNA PCR array
system was procured from Qiagen (Qiagen, Hilden,
Germany). The primary antibodies (p-H2AX (Cat No
9718), Cleaved Casapse-3 (Cat No 9661), c-Jun (Cat No
9165), and Beta Actin (Cat No 4967) were procured from
the Cell Signaling Technology (Cell Signaling Technologies,
Boston, MA, USA) The secondary antibodies used in the
experiments were from Chemicon (Chemicon, Temecula,
CA, USA). All other chemicals were purchased from Sigma
(St. Louis, MO, USA) unless otherwise stated.
UV-B irradiation
The UV-irradiation system (Vilber Lourmat, France), was
equipped with calibrated UV-B detection probe and com-
prised of an array of 1.2 m long UV-B emitting tubes for
regulated emission of radiation through a microprocessor-
controlled RMX-3 W radiometer. The spectral emission
of UV-B source used for the experiments ranged from 280
to 320 nm with a peak at 315 nm. Intensity of UV-B
(0.6 mW/cm2 for 1 h) selected for irradiation was based
on dosimetry carried out between 12.00 Noon to 1.00 PM
and was parallel to the ambient intensity of UV-B radi-
ation in sunlight at Lucknow (26°45′N latitude and 80°50′
E longitude at 146 m above the mean sea level). UV-B
irradiation was carried out in a temperature controlled
(25°C ± 2°C) radiation chamber. The riboflavin samplesin glass Petri dishes (60 × 15 mm) were placed at a
minimum distance of 22.0 cm from the source of radiation.
Liquid chromatography-mass spectrometry (LC-MS/MS)
analysis
Mass spectrometric detection was performed on an API
4000 QTRAP mass spectrometer (Applied Biosystems,
Canada). RF was optimized by continuous infusion at
10 μl min−1 using syringe pump (Model ‘11’, Harvard ap-
paratus). Zero air and nitrogen gas were used as source
and curtain gas, respectively. The optimized declustering
potential was 120 Volt. At these optimized conditions,
Q1 scan for control and test samples was performed.
Cell culture and transfections
SH-SY5Y cells were maintained plated in 100-mm cul-
tured dishes and cultured in Eagle’s modified essential
medium/ F12, supplemented with 10% fetal calf serum,
1% of a mixture of penicillin/streptomycin/nystatin, 1 mM
sodium piruvate, 0.1 Mm non-essential amino acids,1.5 g/L
sodium bicarbonate and 2 mM L-Glutamine. RF was dis-
solved in saline (0.9% NaCl) and stock solutions (10 mM)
were further diluted in the culture media prior to the use
in experiments. The cells were plated at 1×104cells per well
in 96-well or 5×105cells per well in 6 well microtiter plates
for the assays. For the primary cortical neuronal cultures,
embryonic day 16–18 pups were obtained from pregnant
Sprague Dawley rats, anesthetized with tribromoethanol
(350 mg/kg, i.p.). Meninges were carefully removed and
isolated cerebral cortices were dissociated with 8.2 U/ml
papain (Worthington Biochemical, Lakewood, NJ) for
30 min at 37°C in a shaking water bath. Subsequently,
fetal bovine serum and trypsin inhibitor were used to
stop digestion. The tissue suspension was then triturated
thoroughly using a pasteur pipette. Freshly dissociated
cells were seeded at 2 × 105 cells/cm2 into 96-well plastic
plates coated with L-polyornithine (10 μg/ml) and then in-
cubated in Neurobasal medium (Invitrogen, Carlsbad,
CA) with 2% B-27 supplement, Glutamax (1:100) (Invitro-
gen, Calsbad, CA), penicillin, and streptomycin at 37°C
with 5% CO2 and 95% air. The medium was changed 24 h
after plating, and half of the medium was changed every
3 days. Experiments were conducted after three changes
of media. Immunocytochemical analysis of neuronal
marker protein gene product 9.5 (PGP 9.5) (Chemicon
International, Inc., Temecula, CA) was used to confirm
the purity of neuronal cells. The transfections were car-
ried out by using either Lipofectamine 2000 or RNAiMax
(Invitrogen, Carlsbad,CA,USA) as per a standardized
protocol [16].
Measurement of cell viability and LDH secretion
The cell viability and LDH secretion were quantified in
the SH-SY5Y cell line and cortical neuron cultures using
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MD, USA) and the LDH quantification kit (Biovision, CA,
USA) as per the manufacturer’s instructions.
Oxygen glucose deprivation
For oxygen glucose deprivation (OGD) experiments, the
media of cultured SH-SY5Y cell line or cortical neurons
were replaced with pre gassed 1X Hank’s balanced salt
solution (HBSS, 140 mM NaCl, 5 mM KCl, 2 mM CaCl2,
10 mM HEPES, 30 μM glycine, pH 7.4) and placed in a
Billups-Rothenberg modular incubator chamber (Del Mar,
CA) and flushed with a gas mixture of 5% CO2 and
95% N2 for 10 min. The chamber was then sealed and
placed into a humidified CO2 incubator at 37°C. After
60 min in the hypoxic chamber, the OGD treatment was
stopped by replacing HBSS with the respective cell culture
media. The cells were then placed back to normoxic condi-
tions and incubated for 24 h for the functional assays.
Focal cerebral ischemia and neurological deficit score
evaluation
Focal cerebral ischemia was simulated in a rat model of
cerebral stroke through the middle cerebral artery occlu-
sion (MCAO). Adult male Sprague–Dawley (SD) rats
(220 ± 20 g) were obtained from the National Laboratory
Animal Centre, Central Drug Research Institute (CDRI),
Lucknow, used for experiment. The experimental animals
were approved by Institutional Animal Ethical Committee
(IAEC) and all animal experiments were carried out in ac-
cordance with the institutional guidelines. Rats were
housed in cages in a temperature-controlled (25°C ± 1°C)
environment, provided free access to food and purified
drinking water ad libitum. The rats were divided into 4
groups of 6 rats each as follows: Group I: Sham operated
group; handled as other groups, except MCAO was not
done. Group II: Ischemic brain damage induced by
MCAO, treated with saline as vehicle. Group III: Ischemic
brain damage, treated with 10 mg/kg of RF 30 min before
MCAO. Group IV: Ischemic brain damage, treated with
10 mg/kg UV-B irradiated RF 30 min before MCAO. The
induction of MCAO and evaluation of the neurological
deficit score was conducted as per a standardized proto-
cols [17,18]. At the end of the experimental period the an-
imals were sacrificed through decapitation.
Western blotting
Western blotting experiments were carried out using
previously standardized protocol [16]. Briefly both cells
and tissues lysates were prepared in cell lysis buffer (50
mMol/L Tris–HCl, 150 mmol/L NaCl, 1% NP40, 0.5%
SDS, and 1% deoxycholic acid). The lysates were subse-
quently heated at 95°C for 5 minutes and centrifuged at
14,000X g for 5 min and the supernatants were stored
at −80°C until use. 50 μg of estimated protein per samplewas loaded on to 10% SDS-PAGE gels. Blocking was
done with 2% BSA and blots were incubated in primary
antibodies (1:5000) over night at 4°C. The blots were
washed thrice in 0.1% Tween-20 in PBS and incubated
with HRP-conjugated secondary antibody (1:2000) for
1 h at room temperature. Blots were developed using the
chemiluminescent substrate (Millipore, Billerica, CA, USA).
MiRNA analysis
Total miRNA was isolated from the cortical tissues samples
and cortical neuronal cultures using the Nucleospin miRNA
kit (Macherey–Nagel, Duren, Germany). The change in
miRNA expression was measured using the RT2 miRNA
PCR array system (Qiagen, Hilden, Germany). Expression
analysis of 376 miRNA sequences was performed as per the
manufacturer’s instructions in a Light Cycler 480 II (Roche
Diagnostics, Mannheim, Germany). The PCR conditions
were set according to the manufacturer’s instructions.
Data analysis was performed using the RT2 Profiler
PCR Array Data Analysis Template (Qiagen, Hilden,
Germany). Normalization of the data was done using four
miRNAs (hsa-SNORD-44, hsa-SNORD47, hsa-SNORD48
and hsa-U6) and the relative miRNA expression levels
were calculated with 2-ΔΔCt. All the experiments were per-
formed in triplicate.
Site directed mutagenesis and real-time PCR
The expression vector of c-Jun deletion mutant N1–220
was generated in pcDNA3.1 vector by PCR. The expres-
sion vectors of c-Jun mutant (pcDNA3.1junS63/73A and
pcDNA3.1junM3A) were generated in pcDNA3.1 vector
by PCR using a previously standardized site-directed
mutagenesis method [19]. All generated constructs were
verified by sequencing.
Real-time PCR analysis
mRNA from the samples was extracted using Trizol. To
evaluate the level of c-Jun expression, realtime PCR with
SYBR Green dye was used in a LC480 II light cycler real
time PCR machine. The real time PCR reaction mixture
contained 10 μl Syber Green Super Mix, 100 nM of each
primer (c-Jun Forward Primer: 3′- TGATGACGCCTTA
CGTGGTA-5′ and Reverse Primer:3′- ACAAGGTGTT
CCGAGCTGTT-5′) and 1 μl cDNA. All samples were
run in triplicates and each experiment was repeated at
least three times independently. Each sample was nor-
malized on the basis of GAPDH.
Luciferase assay
The luciferase reporter plasmids containing the wild-type
3′UTR with the miR-203 binding site of c-Jun was ob-
tained from Genecopoeia (Rockville, MD, USA). respect-
ively. Cortical neuron cells were transfected with the
luciferase constructs (100 ng per 24-well) and pre-miR-203
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Lipofectamin 2000 (Invitrogen). Luciferase activity was
measured after 24 h using the Dual Luciferase Re-
porter Assay according to the manufacturer’s instruc-
tions (Promega, Madison, WI, USA).
Statistical analysis
All the values are represented as mean ± SEM from at
least three independent experiments. Data was analysed
using One-way ANOVA followed by Newman Keuls
multiple comparision test. Values with p < and =0.05 were
considered to be significant.
Results
UV-B irradiation induces degradation of RF and decreases
its neuroprotective effects in vitro
RF is known to exert neuroprotective effects [9-12] and is
vulnerable to photodegradation [13-15]. We therefore
assessed the effects of UV-B irradiation induced photode-
gradation of RF. The absorption spectrum of RF (5 μg/ml)
in physiological saline at different intensities (Figure 1A) is
characterized by one intense absorption peak at 267 nm inA
Absorbance
spectra of RF under 
UV-vis-Spectrophotometer
C
Figure 1 Absorbance spectra of RF under UV-B by UV–vis-Spectropho
absorbance in UV-B region. (B) Absorbance spectra of UV-B-RF in different
of RF photodegradation and photoproducts ion formation under UV-B (0.6 m
data of three independent experiments.the UV-B region. The photodegradation study was per-
formed under UV-B (0.6 mW/cm2) for 1, 2, 3 and 4 h.
The result showed 1 h irradiation of RF shifted the ab-
sorption maxima towards the UV range (Figure 1B, C).
These results were further confirmed through the LC-
MS/MS analysis. LC-MS/MS (Q1 scan) analysis was per-
formed with RF (376 Da) and UV-B irradiated RF (Figure 2
A, B). Two major photoproducts were obtained with mo-
lecular mass of P1 (360.4 Da) and P2 (343.2 Da), respect-
ively. These two ionic photoproducts formed by elimination
of hydroxyl group after UV-B irradiation. In LC-MS/MS
spectra of RF, photoproduct ion formed at collision energy
was found to be different from photoproduct of UV-B irra-
diated sample (Figure 1C). Next, we explored whether the
photodegradation of RF influenced its neuroprotective
effects. We subjected SH-SY5Y cells to oxygen glucose
deprivation/reperfusion (OGD/R) and assessed the neuro-
protective effects of UV-B-RF and RF through quantifica-
tion of the LDH release and cell viability. The results
indicated that OGD significantly increased cellular stress
indicated by the increased (p < 0.01) LDH secretion






Absorbance spectra of RF
under UV-B (0.6mW/cm2)
B
tometer. (A) Absorbance spectra of RF (5 μg/ml) showed maximum
time interval (1 to 4 h) compared to RF. (C) Schematic representation
W/cm2 for 1 h) irradiation, identified by LC-MS/MS analysis. Representative
Figure 2 UV-B irradiation induces photodegradation and attenuation of the neuroprotective effects of RF in human neuroblostoma
SH-SY5Y cell lines. (A) LC-MS/MS spectrum of parent RF (376 Da) and (B) two major photoproducts P1 (360.4 Da) and P2 (343.2 Da) after UV-B
(0.6 mW/cm 2 for 1 h) irradiation. (C) RF treatment significantly inhibits OGD induced LDH release compared to that of UV-B-RF treatment (D) RF
treatment significantly rescues cell viability compared to that of UV-B-RF treatment in Human neuroblostoma SHSY5Y cell line. The average of
three independent experiments performed in triplicate is shown. Statistical significance was analyzed by ANOVA. Values are the mean ± SEM *p < 0.05
and **p < 0.01 vs. RF treated and control group.
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induced LDH release by 46.2% while in the UV-B-RF
treated group the reduction of LDH secretion was only
15.9% (Figure 2C). Similarly, OGD significantly (p < 0.01)
reduced (~23.8%) the cell viability in the control group.
Treatment of SH-SY5Y cells with RF significantly (p < 0.01)
increased cell viability (~70.3%) compared to that of the
UV-B-RF treatment (~24.2%) (Figure 2D). Collectively,
these results showed that the UV-B irradiation decreased
the cytoprotective effect of RF in the human neuroblos-
toma SH-SY5Y cell line in vitro.
UV-B-RF has attenuated neuroprotective effects in a rat
model of cerebral ischemia
RF is known to have neuroprotective effects in a rat model
of cerebral ischemia [10,12]. As our results indicatedattenuated neuroprotective effects of UV-B-RF in vitro,
we next tried to assess, the neuroprotective effects of
UV-B irradiation in a rat model (middle cerebral artery
occlusion) of cerebral ischemia. The results showed that
RF treatment (10 mg/kg body weight, i.p.) showed signifi-
cant neuroprotective activity compared to that of the
UV-B-RF (10 mg/kg body weight, i.p.) as indicated by
the decreased neuronal cell death in single coronal brain
section (Figure 3A) and p-H2AX and Caspase-3 immuno-
bloting analysis of brain lysates (Figure 4A,B). UV-B-RF
treatment also failed to reduce the infract volume (Figure 3B)
and edema volume (Figure 3C). Further, the evaluation of
the neurological deficit scores (on days 1, 2, 3, 7, 14 and
28) clearly indicated that RF treated experimental groups
had significantly improved neurological scores compared
to that of the of the UV-B-RF treated groups (Figure 3D).














Figure 3 UV-B irradiation reduces the neuroprotective effects of RF in a rat model cerebral ischemia. (A) TTC staining after 24 h
reperfusion of single coronal brain section treated with either RF or UV-B-RF before MCAO. (B, C) Effect of pretreatment with vehicle, RF and
UV-B-RF on infarct volume (mm3) and Edema volume (mm3) calculated from image-J analysis software. (D) Total neurological deficit score
was evaluated to see neurological impairment after 1 to 28 days successive treatment. Statistical significance was analyzed by ANOVA.







Figure 4 RF and UV-B-RF have differential effects on DNA damage and caspase-3 activation in the cortical region of brain subjected to
ischemic injury. Immunoblotting analysis of (A) p-H2AX and (B) Cleaved caspase-3 in cell lysates prepared from the cortical regions of the brain
subjected to ischemic injury and pretreated with either vehicle (saline), RF (10 mg/kg i.p.), UV-B-RF(10 mg/kg, i.p.) or miR-203 mimic (200 nM/kg i.p.).
Representative images of at least three independent experiments are shown.
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attenuated neuroprotective effects in a rat model of cerebral
ischemia in vivo.
UV-B irradiation differentially regulates RF induced
expression of miR-203 in-vivo and in-vitro
Experimental evidence has established the role of miR-
NAs as critical regulators of neuronal cell survival and
cell death [3-7]. As the earlier results indicated that the
UV-B irradiation decreased the neuroprotective ability of
RF in vivo, we next tried to assess the possible role of
miRNAs involved in this process. The miRNA PCR array
analysis indicated that the RF preconditioning increased
expression of miR-203, whereas UV-B-RF treatment in-
duced only 0.25 and 0.50 fold change in its expression in
cortical neuron cells and cortical brain tissue respect-
ively (Table 1). We further tried to confirm this finding
using primary cortical neuron cultures. The results indi-
cated that RF treatment significantly increased the miR-
203 levels (Figure 5A) compared to that of UV-B-RF
treatment (Table 1). Similarly, RF treatment significantly
decreased the OGD induced LDH secretion, compared to
that of the UV-B-RF treatment (Figure 5B). This finding
was further confirmed by the comparable reduction in
LDH secretion through miR-203 over expression in cor-
tical neurons (Figure 5B). These results clearly indicated
that, RF treatment sustained the increased expression
of miR-203 in neuronal cells while UV-B-RF has noTable 1 Effect of RF and UV-B-RF treatment on differential
expression of miRNAs cerebral cortex in vivo and cortical
neuronal culture in vitro
Expression of miRNAs in rat cerebral cortex treated RF and
UV-B-RF
miRNAs RF Pre- treatment
(Fold Change)




miR-203 3.50 0.05 0.50 0.05
miR-23a 1.10 0.30 1.20 0.25
miR-10b 1.20 0.40 1.10 0.30
miR-145 1.20 0.60 1.10 0.35
miR-350 1.30 0.45 1.20 0.50
miR-27a 0.90 0.64 0.80 0.49
Expression of miRNAs in rat primary cortical neurons treated
with RF and UV-B-RF
miR-203 4.9 0.05 0.25 0.05
miR-23a -1.2 0.06 -0.80 0.25
miR-10b -1.3 0.20 -1.10 0.30
miR-145 1.1 0.40 0.94 0.35
miR-350 1.4 0.35 1.10 0.50
miR-27a -1.3 0.44 -1.20 0.49
miR-203 expression level increases significantly (p<.05) in cortical brain tissue
and neuronal culture.significant effect on its expression. Collectively, these re-
sults showed that UV-B irradiation alters the RF induced
increase in the expression of miR-203 in neuronal cells
both in vivo as well as in vitro.
UV-B irradiation alters the neuroprotective ability of RF
through modulation of the miR-203/c-Jun signaling pathway
The neuroprotective miR-203 is known to inhibit c-Jun
[20-22] and the inhibition of c-Jun is known to have
neuroprotective effects [23]. Therefore, we next explored
the effects of increased miR-203 expression on c-Jun
levels. Results of the luciferase assay indicated that the
miR-203 targeted the 3′-UTR of c-Jun (Figure 5C). This
was further confirmed through the over expression of
miR-203, in cortical neurons which led to significant de-
crease in the c-Jun expression (Figure 5D). The evalu-
ation of the direct effects of RF and UV-B-RF treatments
on c-Jun expression revealed that RF or miR-203 overex-
pression significantly inhibited c-Jun protein expression
in SH-SY5Y cells subjected to OGD and cortical neuron
cells and cortical brain tissue subjected to ischemic injury,
compared to that of the UV-B-RF treatment (Figure 6A).
Finally we tried to confirm the role of the miR-203/c-Jun
signaling on cortical neuron cell survival in the conditions
of OGD. The results indicated that RF treatment signifi-
cantly increased the neuronal cell survival during condi-
tions of OGD compare to UV-B-RF. The RF induced
increase neuronal cell survival was comparable to the over
expression of miR-203, pharmacological and genomic in-
hibition of c-Jun in cortical neurons (Figure 6). Collect-
ively, these results suggested that the UV-B irradiation
alters the neuroprotective effects of RF through modula-
tion of the miR-203/c-Jun signaling pathway.
Discussion and conclusion
Riboflavin is a water-soluble, heat stable and light sensi-
tive vitamin existing in a wide variety of foods [8,12].
Riboflavin has been reported to have neuroprotective ef-
fects through reduction of ischemic brain injury in focal
cerebral ischemia [10,12]. The recent interest on the re-
lationship of riboflavin and stroke is focused on the ribo-
flavin deficiency in cerebral stroke patients [9] and the
riboflavin regulation of circulating homocysteine con-
centrations, a risk factor for cardiovascular disease [8,12].
However, due to its light sensitive nature we hypothesized
that the atmospherically predominant UV-B irradiation
may alter the functional properties of RF and other phyto-
chemicals such as piperine and curcumin [20] influencing
its neuroprotective effects. Our study showed that UV-B
irradiation significantly alters the neuroprotective effects
of RF.
The miR-203 has neuroprotective effects [20] and it is
known to regulate cell proliferation, differentiation and









Figure 5 UV-B irradiation differentially regulates RF induced expression of miR-203 in vivo and in vitro. (A) Cortical neuronal cells were
subjected to OGD were treated with either RF (5 μM) or UV-B-RF (5 μM). RF significantly increased the expression of miR-203 compared to that of
UV-B-RF (B) RF treatment or miR-203 overexpression significantly decreased the LDH secretion compared to that of UV-B-RF treatment. (C) Percentage
c-Jun 3′ UTR luciferase activity assay of wild type and mutated c-Jun in cortical neuron pre-treated with vehicle control and miR-203. (D) c-Jun expression
in cortical neuron subjected to OGD with pre-treatment of mock, Control and miR-203. The average of three independent experiments performed











Figure 6 UV-B irradiation modulates the miR-203/c-Jun signaling pathway for altering the neuroprotective effect of RF. (A)
Immunoblotting analysis of c-Jun expression in cell lysates from SH-SY5Y cell line and primary cortical neurons subjected to OGD and cortical
regions of the brain subjected to ischemic injury and pretreated with either vehicle (saline), RF (10 mg/kg i.p.), UV-B-RF(10 mg/kg, i.p.) or
miR-203 mimic (200 nM/kg i.p.). Representative images of at least three independent experiments are shown. (B) Cortical neuronal cells
were subjected to OGD and treatment with RF (5 μM), miR-203 mimic (5 μM) , SP600125 (20 μM), c-Jun shRNA (50 nM/ml) and UV-B-RF
(5 μM) treatment. Cell viability of cortical neurons was measured using the CCK-8 kit. UV-B-RF had significantly lower cell viability compared
to that of the treated groups. The average of three independent experiments performed in triplicate. Statistical significance was analyzed by
ANOVA. Values are the mean ± SEM. *p < 0.05 and **p < 0.01 vs. RF treated group.
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significantly increased expression of miR-203, decreased
OGD induced LDH secretion and increased cell survival
compared to that of the UV-B-RF treatment. We further
identified c-Jun as a target of miR-203 and its inhibitory
effect on c-Jun expression in agreement with earlier
studies [21,22]. This may represent a critical step in the
regulation of the neuroprotective effects of RF. The rela-
tive decrease in the miR-203 expression with respect to
the controls in the cultured neuronal cells or brain tis-
sues treated by UV-B-RF was 0.25 and 050 folds respect-
ively. This finding may possibly due to the existence of a
regulatory circuit, in which miR-203 and c-Jun mutually
inhibit each other. This may represent a critical step in
the neuroprotective action of RF. As c-Jun is a negative
regulator of miR-203, the circuit constitutes a feedback
loop, whereby RF treatment in neuronal cells had in-
creased levels of miR-203 expression, inducing an inhib-
ition of c-Jun resulting in neuroprotection [23,24], where
as UV-B irradiated RF was devoid of this effect. Thus, our
results suggest a novel notion: RF preconditioned neur-
onal cells have increased while UV-B-RF preconditioned
neuronal cells have no marginal change in miR-203 ex-
pression thereby leading to differential effects on c-Jun in-
hibition and neuroprotection. Interestingly, we found RF
treatment both in vivo and in vitro significantly increased
miR-203 expression and subsequent c-Jun inhibition lead-
ing to neuroprotection. Further studies will be needed to
understand whether this signaling pathway is a target of
other neuroprotective or neurotoxic agents.
Taken together our studies suggest that (i) UV-B irradi-
ation induces attenuation of the neuroprotective effects of
RF (ii) through the modulation of the miR-203/c-Jun sig-
naling pathway. Our current results strongly suggest that
the potential of UV-B irradiation may be further investi-
gated for its potential as a regulator of other cytoprotec-
tive/neuroprotective signaling pathways. Importantly,
further studies are required to assess the translational
value of the therapeutic activation of the miR-203/c-Jun
signaling pathway for neuroprotection.Competing interests
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